US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
RSS Feeds

Biotechnology Industry Research & Market Reports

8  9  10  11    13    15  16  17  
Fibroblast Growth Factor Receptor 4 (FGFR4) Inhibitors -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... key objective of the report is to establish the understanding for all the pipeline drugs that fall under Fibroblast Growth Factor Receptor 4 (FGFR4) Inhibitors. This report provides information on the therapeutic development based on ...  |  read more...
USD 1,250
Global Antisense and RNAi Therapeutics Market 2015-2019
11/12/2014 | published by: TechNavio - Infiniti Research Ltd.
... is a RNA-based gene silencing process in which RNA molecules inhibit gene expression by destructing definite mRNA molecules. Antisense technology involves the synthesis of a strand of nucleic acid that would bind to an mRNA ...  |  read more...
USD 2,500
Global Life Sciences BPO Market 2014-2018
11/12/2014 | published by: TechNavio - Infiniti Research Ltd.
... stringent regulatory environment and the patent expiry of several important drugs are leading to diminishing profit margins to many life science companies. This scenario has forced life science companies to outsource their R&D activities and ...  |  read more...
USD 2,500
Global miRNA Market 2015-2019
11/12/2014 | published by: TechNavio - Infiniti Research Ltd.
... of genes and to control diseases by gene silencing. They interact with mRNA molecules and regulate expression of genes by mRNA cleavage, translational repression, and deadenylation. They are generally 17-27 nucleotides long and regulate post-transcriptional ...  |  read more...
USD 2,500
Asia-Pacific Tissue Engineered - Skin Substitutes Market Outlook to 2020
10/31/2014 | published by: GlobalData
... Skin Substitutes market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) within market segments - Synthetic Skin Substitutes, Biosynthetic Skin Substitutes and Biologic Skin Substitutes ...  |  read more...
USD 3,000
BRIC Tissue Engineered - Skin Substitutes Market Outlook to 2020
10/31/2014 | published by: GlobalData
... Skin Substitutes market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) within market segments - Synthetic Skin Substitutes, Biosynthetic Skin Substitutes and Biologic Skin Substitutes ...  |  read more...
USD 3,000
Biotechnology Product Manufacturing
11/24/2014 | published by: First Research, Inc.
... Amgen, Biogen Idec, Genentech (owned by Switzerland-based Roche), and Monsanto, as well as CSL (Australia), Merck KGaA (Germany), Novo Nordisk (Denmark), and the biotech research arms of major international pharmaceutical companies such as Sanofi (France). ...  |  read more...
USD 129
Novartis Partnering 2009-2014
11/1/2014 | published by: Current Partnering
... require to better understand Novartis and its partnering interests and activities over the past five years. On demand company reports are prepared upon purchase to ensure inclusion of the most up to date deal and ...  |  read more...
USD 995
Anti-CD19 Antibody -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... for all the pipeline drugs that fall under Anti-CD19 Antibody. This report provides information on the therapeutic development based on the Anti-CD19 Antibody dealing with mechanism of action, comparative analysis at various stages covering Filed, ...  |  read more...
USD 1,250
Anti-CD28 Antibody -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... for all the pipeline drugs that fall under Anti-CD28 Antibody. This report provides information on the therapeutic development based on the Anti-CD28 Antibody dealing with mechanism of action, comparative analysis at various stages covering Filed, ...  |  read more...
USD 1,250
Anti-CD30 Antibody -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... for all the pipeline drugs that fall under Anti-CD30 Antibody. This report provides information on the therapeutic development based on the Anti-CD30 Antibody dealing with mechanism of action, comparative analysis at various stages covering Filed, ...  |  read more...
USD 1,250
Anti-CD33 Antibody -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... for all the pipeline drugs that fall under Anti-CD33 Antibody. This report provides information on the therapeutic development based on the Anti-CD33 Antibody dealing with mechanism of action, comparative analysis at various stages covering Filed, ...  |  read more...
USD 1,250
Anti-CD37 Antibody -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... for all the pipeline drugs that fall under Anti-CD37 Antibody. This report provides information on the therapeutic development based on the Anti-CD37 Antibody dealing with mechanism of action, comparative analysis at various stages covering Filed, ...  |  read more...
USD 1,250
Anti-CD70 Antibody -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... for all the pipeline drugs that fall under Anti-CD70 Antibody. This report provides information on the therapeutic development based on the Anti-CD70 Antibody dealing with mechanism of action, comparative analysis at various stages covering Filed, ...  |  read more...
USD 1,250
Aurora A Kinase Inhibitors -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... to establish the understanding for all the pipeline drugs that fall under Aurora A Kinase Inhibitors. This report provides information on the therapeutic development based on the Aurora A Kinase Inhibitors dealing with mechanism of ...  |  read more...
USD 1,250
Sexually Transmitted Diseases Partnering 2009-2014
11/1/2014 | published by: Current Partnering
... in sexually transmitted diseases partnering deals Top sexually transmitted diseases deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Sexually Transmitted Diseases Partnering 2009-2014 provides understanding and access ...  |  read more...
USD 695
United Therapeutics Corp (UTHR: NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
10/30/2014 | published by: Plunkett Research, Ltd.
... compared to its top competitors and compared to the average for all companies within its primary industry. Benchmarking study for (United Therapeutics Corp) includes growth forecast for its primary industry to the year 2021. The ...  |  read more...
USD 1,795
Agricultural Biotechnology: Emerging Technologies and Global Markets
11/1/2014 | published by: BCC Research
... a compound annual growth rate (CAGR) of 11.0% over the next five years. This report provides: An overview of the global markets for agricultural biotechnology. Analyses of global market trends, with data from 2013, 2014, ...  |  read more...
USD 6,650
Monoclonal Antibody Markets in China
12/1/2014 | published by: Asia Market Information & Development Company
... economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades. This new study examines China's economic ...  |  read more...
USD 4,000
Fibroblast Activation Protein (FAP or Seprase) Inhibitors -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... key objective of the report is to establish the understanding for all the pipeline drugs that fall under Fibroblast Activation Protein (FAP or Seprase) Inhibitors. This report provides information on the therapeutic development based on ...  |  read more...
USD 1,250
Fibroblast Growth Factor (FGF) Inhibitors -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... report is to establish the understanding for all the pipeline drugs that fall under Fibroblast Growth Factor (FGF) Inhibitors. This report provides information on the therapeutic development based on the Fibroblast Growth Factor (FGF) Inhibitors ...  |  read more...
USD 1,250
Fibroblast Growth Factor 1 (FGF-1) Inhibitors -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... of the report is to establish the understanding for all the pipeline drugs that fall under Fibroblast Growth Factor 1 (FGF-1) Inhibitors. This report provides information on the therapeutic development based on the Fibroblast Growth ...  |  read more...
USD 1,250
Fibroblast Growth Factor Receptor 2 (FGFR2) Inhibitors -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... key objective of the report is to establish the understanding for all the pipeline drugs that fall under Fibroblast Growth Factor Receptor 2 (FGFR2) Inhibitors. This report provides information on the therapeutic development based on ...  |  read more...
USD 1,250
Fibroblast Growth Factor Receptor 3 (FGFR3) Inhibitors -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... key objective of the report is to establish the understanding for all the pipeline drugs that fall under Fibroblast Growth Factor Receptor 3 (FGFR3) Inhibitors. This report provides information on the therapeutic development based on ...  |  read more...
USD 1,250
2014-2018 French Tumor Marker Testing Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies
11/12/2014 | published by: VPGMarketResearch.com
... the French cancer diagnostics markets; reviews current and emerging tests; analyzes potential applications of various diagnostic technologies; forecasts sales of major tumor markers and market segment; profiles leading market players and potential entrants; and suggests ...  |  read more...
USD 6,700
8  9  10  11    13    15  16  17